Global differences in dialysis modality mix: The role of patient characteristics, macroeconomics and renal service indicators

Nephrology Dialysis Transplantation

Volumn 28, Issue 5, 2013, Pages 1264-1275

  Van De Luijtgaarden, Moniek W M ^a   Jager, Kitty J ^a   Stel, Vianda S ^a   Kramer, Anneke ^a   Cusumano, Ana ^b   Elliott, Robert F ^c   Geue, Claudia ^d   MacLeod, Alison M ^c   Stengel, Benedicte ^e,f   Covic, Adrian ^g   Caskey, Fergus J ^h,i  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Centro Nacional de Genetica Medica de Buenos Aires   (Argentina)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e INSERM   (France)

^f UNIVERSITÉ PARIS SACLAY   (France)

^g GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^h Richard Bright Renal Unit   (United Kingdom)

ⁱ UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

dialysis; epidemiology; health policy; macroeconomics

Indexed keywords

ARTICLE; COST; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIALYSIS EQUIPMENT AND SUPPLIES; GERIATRIC PATIENT; GROSS NATIONAL PRODUCT; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROFIT; REIMBURSEMENT;

DIALYSIS; EPIDEMIOLOGY; HEALTH POLICY; MACROECONOMICS;

AGED; DIABETIC NEPHROPATHIES; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HUMANS; KIDNEY FAILURE, CHRONIC; PROGNOSIS; RENAL DIALYSIS; RENAL REPLACEMENT THERAPY; RISK FACTORS; SURVIVAL RATE;

EID: 84877954084     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft053     Document Type: Article

References (62)

1. De Vecchi AF, Dratwa M, Wiedemann ME. Healthcare systems and end-stage renal disease (ESRD) therapies-an international review: costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant 1999; 14: 31-41
2. Eggers PW. Has the incidence of end-stage renal disease in the USA and other countries stabilized? Curr Opin Nephrol Hyper-tens 2011; 20: 241-245
3. Kramer A, Stel V, Zoccali C et al. An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006. Nephrol Dial Transplant 2009; 24: 3557-3566
4. Schieppati A, Remuzzi G. Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int Suppl 2005; 98: S7-S10
5. Bloembergen WE, Port FK, Mauger EA et al. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995; 6: 177-183
6. Collins AJ, Hao W, Xia H et al. Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis 1999; 34: 1065-1074
7. Fenton SS, Schaubel DE, Desmeules M et al. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis 1997; 30: 334-342
8. McDonald SP, Marshall MR, Johnson DW et al. Relationship between dialysis modality and mortality. J Am Soc Nephrol 2009; 20: 155-163
9. van de Luijtgaarden MW, Noordzij M, Stel VS et al. Effects of co-morbid and demographic factors on dialysis modality choice and related patient survival in Europe. Nephrol Dial Transplant 2011; 26: 2940-2947
10. Quinn RR, Hux JE, Oliver MJ et al. Selection bias explains apparent differential mortality between dialysis modalities. J Am Soc Nephrol 2011; 22: 1534-1542
11. Sens F, Schott-Pethelaz AM, Labeeuw M et al. Survival advantage of hemodialysis relative to peritoneal dialysis in patients with end-stage renal disease and congestive heart failure. Kidney Int 2011; 80: 970-977
12. Berger A, Edelsberg J, Inglese GW et al. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease. Am J Manag Care 2009; 15: 509-518
13. Salonen T, Reina T, Oksa H et al. Cost analysis of renal replacement therapies in Finland. Am J Kidney Dis 2003; 42: 1228-1238
14. Haller M, Gutjahr G, Kramar R et al. Cost-effectiveness analysis of renal replacement therapy in Austria. Nephrol Dial Transplant 2011; 26: 2988-2995
15. Neil N, Guest S, Wong L et al. The financial implications for Medicare of greater use of peritoneal dialysis. Clin Ther 2009; 31: 880-888
16. Sennfalt K, Magnusson M, Carlsson P. Comparison of hemodialysis and peritoneal dialysis-a cost-utility analysis. Perit Dial Int 2002; 22: 39-47
17. Bass EB, Wills S, Fink NE et al. How strong are patients' preferences in choices between dialysis modalities and doses? Am J Kidney Dis 2004; 44: 695-705
18. Blake PG The complex economics of modality selection. Perit Dial Int 2004; 24: 509-511
19. Dor A, Pauly MV, Eichleay MA et al. End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF). Int J Health Care Finance Econ 2007; 7: 73-111
20. Goovaerts T, Jadoul M, Goffin E. Influence of a pre-dialysis education programme (PDEP) on the mode of renal replacement therapy. Nephrol Dial Transplant 2005; 20: 1842-1847
21. Horl WH, de AF, Williams PF. Healthcare systems and end-stage renal disease (ESRD) therapies-an international review: access to ESRD treatments. Nephrol Dial Transplant 1999; 14: 10-15
22. Jung B, Blake PG, Mehta RL et al. Attitudes of Canadian nephrol-ogists toward dialysis modality selection. Perit Dial Int 1999; 19: 263-268
23. Just PM, de Charro FT, Tschosik EA et al. Reimbursement and economic factors influencing dialysis modality choice around the world. Nephrol Dial Transplant 2008; 23: 2365-2373
24. Nissenson AR, Prichard SS, Cheng IK et al. ESRD modality selection into the 21st century: the importance of non-medical factors. ASAIO J 1997; 43: 143-150
25. van Biesen W, Veys N, Lameire N et al. Why less success of the peritoneal dialysis programmes in Europe? Nephrol Dial Transplant 2008; 23: 1478-1481
26. Jager KJ, Korevaar JC, Dekker FW et al. The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in The Netherlands. Am J Kidney Dis 2004; 43: 891-899
27. Caskey FJ, Stel VS, Elliott RF et al. The EVEREST study: an international collaboration*. NDT Plus 2010; 3: 28-36
28. Caskey FJ, Kramer A, Elliott RF et al. Global variation in renal replacement therapy for end-stage renal disease. Nephrol Dial Transplant 2011; 26: 2604-2610
29. Kramer A, Stel VS, Caskey FJ et al. Exploring the association between macroeconomic indicators and dialysis mortality. Clin J Am Soc Nephrol 2012; 7: 1655-1663
30. Jager KJ, Zoccali C, Macleod A et al. Confounding: what it is and how to deal with it. Kidney Int 2008; 73: 256-260
31. Kleinbaum DG. Applied Regression Analysis and Other Multivariable Methods. Pacific Grove: Duxbury Press, 1998, 389-390
32. Fox J, Monette G. Generalized collinearity diagnostics. J Am Stat Assoc 1992; 87: 178-183
33. de Jager DJ, Grootendorst DC, Jager KJ et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 2009; 302: 1782-1789
34. Liem YS, Wong JB, Hunink MG et al. Comparison of hemodialy-sis and peritoneal dialysis survival in The Netherlands. Kidney Int 2007; 71: 153-158
35. Vonesh EF, Snyder JJ, Foley RN et al. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int 2004; 66: 2389-2401
36. Xue JL, Everson SE, Constantini EG et al. Peritoneal and hemo-dialysis: II. Mortality risk associated with initial patient characteristics. Kidney Int 2002; 61: 741-746
37. Miskulin DC, Meyer KB, Martin AA et al. Comorbidity and its change predict survival in incident dialysis patients. Am J Kidney Dis 2003; 41: 149-161
38. van Manen JG, van Dijk PC, Stel VS et al. Confounding effect of comorbidity in survival studies in patients on renal replacement therapy. Nephrol Dial Transplant 2007; 22: 187-195
39. Mehrotra R, Kermah D, Fried L et al. Chronic peritoneal dialysis in the United States: declining utilization despite improving outcomes. J Am Soc Nephrol 2007; 18: 2781-2788
40. Bouvier N, Durand PY, Testa A et al. Regional discrepancies in peritoneal dialysis utilization in France: the role of the nephrolo-gist's opinion about peritoneal dialysis. Nephrol Dial Transplant 2009; 24: 1293-1297
41. Castledine C, Gilg J, Rogers C et al. UK Renal Registry 13th Annual Report (December 2010): Chapter 15: UK renal centre survey results 2010: RRT incidence and use of home dialysis modalities. Nephron Clin Pract 2011; 119: c255-c267
42. Mehrotra R, Khawar O, Duong U et al. Ownership patterns of dialysis units and peritoneal dialysis in the United States: utilization and outcomes. Am J Kidney Dis 2009; 54: 289-298
43. Mignon F, Michel C, Viron B. Why so much disparity of PD in Europe? Nephrol Dial Transplant 1998; 13: 1114-1117
44. Wauters JP, Uehlinger D. Non-medical factors influencing peritoneal dialysis utilization: the Swiss experience. Nephrol Dial Transplant 2004; 19: 1363-1367
45. Li PK, Chow KM. The cost barrier to peritoneal dialysis in the developing world-an Asian perspective. Perit Dial Int 2001; 21: S307-S313
46. Slade EP, Anderson GF. The relationship between per capita income and diffusion of medical technologies. Health Policy 2001; 58: 1-14
47. MacGregor MS, Agar JW, Blagg CR Home haemodialysis- international trends and variation. Nephrol Dial Transplant 2006; 21: 1934-1945
48. van Biesen W, Lameire N, Peeters P et al. Belgium's mixed private/public health care system and its impact on the cost of end-stage renal disease. Int J Health Care Finance Econ 2007; 7: 133-148
49. Diaz-Buxo JA, Crawford-Bonadio TL, St PD et al. Establishing a successful home dialysis program. Blood Purif 2006; 24: 22-27
50. Mendelssohn DC, Langlois N, Blake PG Peritoneal dialysis in Ontario: a natural experiment in physician reimbursement methodology. Perit Dial Int 2004; 24: 531-537
51. Golper TA, Saxena AB, Piraino B et al. Systematic barriers to the effective delivery of home dialysis in the United States: a report from the public policy/advocacy committee of the north American chapter of the international society for peritoneal dialysis. Am J Kidney Dis 2011; 58: 879-885
52. Brown EA, Johansson L, Farrington K et al. Broadening options for long-term dialysis in the elderly (BOLDE): differences in quality of life on peritoneal dialysis compared to haemodialysis for older patients. Nephrol Dial Transplant 2010; 25: 3755-3763
53. Couchoud C, Moranne O, Frimat L et al. Associations between comorbidities, treatment choice and outcome in the elderly with end-stage renal disease. Nephrol Dial Transplant 2007; 22: 3246-3254
54. O'Hare AM, Johansen KL, Rodriguez RA. Dialysis and kidney transplantation among patients living in rural areas of the United States. Kidney Int 2006; 69: 343-349
55. ERA-EDTA Registry. ERA-EDTA Registry Annual Report 2009. Academic Medical Center, Department of Medical Informatics, Amsterdam, The Netherlands, 2011
56. Jain AK, Blake P, Cordy P et al. Global trends in rates of peritoneal dialysis. J Am Soc Nephrol 2012; 23: 533-544
57. Department of Health. Update on best practice tariffs 2011 13-12-2011
58. Report of the Delegates. National Summit on Home Dialysis Policy. 25-4-2012. Washington, DC
59. Earle KK, Porter KA, Ostberg J et al. Variation in the progression of diabetic nephropathy according to racial origin. Nephrol Dial Transplant 2001; 16: 286-290
60. JS Gujral ABJINRJB. The prevalence of chronic renal failure in known diabetic and non-diabetic White Caucasians and South Asians. Practical Diabetes Int 1997; 14: 71-74
61. Docteur E, Oxley H. Health-care systems: lessons from the reform experience. OECD 2003; 28: 1-94
62. Durand PY, Verger C. The state of peritoneal dialysis in France. Perit Dial Int 2006; 26: 654-657